An investigation of the reductive effect of blood pressure and increment of urinary sodium excretion with calcium and potassium supplementation in children with sodium sensitivity is conducted. In total of 261 school children who had completed a 2-year doubleblinded, placebo-controlled trial with calcium and potassium supplementation salt sensitivity, with a salt volume expansion and contraction protocol, was determined. The results showed that in children with salt sensitivity, the increase in blood pressure in the supplementary group was lower by 4.3/4.8 mmHg than that in the placebo group (Po0.05), while no significant change was found between the supplementary group and placebo group in children with nonsalt sensitivity. With calcium and potassium supplementation, the night urinary sodium excretion in children with salt sensitivity was significantly increased (Po0.01), and it is negatively correlated with the increase in blood pressure. It was suggested that a moderate increase of calcium and potassium intake in children with salt sensitivity, through interaction with sodium, can promote urinary sodium excretion and may play contribute to the prevention of hypertension.
Introduction
Epidemiological and clinical studies have shown that potassium intake has an important role in regulating blood pressure (BP) in both the general population and people with high BP. [1] [2] [3] [4] A metaanalysis supports the premise that increased potassium intake may play a role in the prevention and treatment of hypertension, especially in those who are unable to reduce their intake of sodium. 3 Recently, randomized placebo-controlled trials of potassium on BP in a Chinese population have indicated that moderate potassium supplementation resulted in a substantial reduction in systolic blood pressure (SBP). 4 Some clinical trials concluded that calcium supplementation induces a considerable sodium loss in urine, which is very likely to result in the hypotensive effect. 5 Also some available evidence indicates that increasing dietary calcium intake may result in reduction in fat mass as well as in BP. 6 Salt sensitivity is an intermediate phenotype of essential hypertension, 7, 8 people with salt sensitivity and who are exposed for a long time to a highsalt diet environment will develop high BP. The metabolic abnormality of common cations such as sodium, potassium and calcium play an important role in the duration of hypertension in salt sensitivities. Increased dietary calcium in salt-sensitive (SS) subjects will attenuate the BP effect of salt, and lower pressure in these individuals. 9 However, there were also some inverse results. A controlled longterm oral calcium supplementation trial in essential hypertension did not support the suggestion that calcium supplements lower arterial pressure in middle-aged subjects with mild to moderate essential hypertension. 10 Another trial of combined supplements with potassium, calcium and magnesium in hypertensives provided little evidence of an important role of combinations of cation supplements in the treatment of mild or borderline hypertension. 11 However, there were few clinical or epidemiological studies or evidences about the BP effect of these cations in Chinese children, who consume low potassium and calcium diet but highsalt diet. Our previous study demonstrated that moderate supplementation with potassium and calcium in children could diminish the extent of age-related BP increase. 12 We conducted this indepth study to obtain more information about these BP effects on SS children and the corresponding results on sodium metabolism and urinary sodium excretion.
Materials and methods

Study children
The study was a randomized, double-blind, placebocontrolled clinical trial to test the efficacy of supplements with 10 mmol potassium and 10 mmol calcium on lowering BP in children. Six classes, 308 pupils, in grade three or grade four from a primary school in Hanzhong, China, were enrolled in the study. Children were excluded from participation for any of the following conditions: (1) secondary hypertension; (2) history of cardiovascular disease, diabetes mellitus, chronic obstructive pulmonary disease, etc; (3) serum creatinine X1.7 mg/dl at the screening examination and (4) inability or unwillingness to participate in all aspects of the study. Informed consent was obtained before randomization. The protocol was approved from the ethics committee of our university hospital. To assure the ethical aspects of this research, we called together these children and their parents and teachers and clearly explained the program and protocol. Every child was asked to sign an informed consent with their guardians' consent.
Randomization
Class-cluster sampling and randomized method were considered, and all the studied school-classes were allocated to the supplemental group and placebo control group. Randomization was based on assignments generated by a computer program and the assignment schedule was concealed in an ordered set of sealed envelopes, opened only after the study coordinator had confirmed eligibility. Apart from the study coordinator, all research personal, including BP technicians, were unware of the treatment assignment, as were the participants.
Intervention
Children were instructed to take a study tablet every day for 2 years. One tablet contained either 10 mmol potassium and 10 mmol calcium or placebo (Zhongyao Pharmaceuticals, Hanzhong, China). The placebo was identical to the potassium and calcium tablet in appearance and taste. The double-blinded method was used in the tablet administration. During the 2-year intervention, participants were instructed to maintain their usual level of sodium intake. Every morning before the first class, study tablets were ingested with water by the pupils with the teacher monitoring the intake. For those children who had left school for a short time, guardians would get the tablets and assure that there were ingested by them. Also such a strategy was used in vacations or festivals. Adherence to the intervention was assessed by pill count and by measurement of urinary potassium excretion.
Measurements
Demographic information, medical history, medicine use, and physical activity were collected at baseline. BP was measured by experienced study staff members who were trained and certified in the use of Hawksley random zero sphygmomanometers. BP readings were taken from the right arm with appropriately sized cuffs after the participant had been quietly seated for 5 min. The first sound of Korotkoff was taken as the systolic pressure, and the fourth phase as the diastolic pressure. Three BP measurements were obtained at baseline and at follow-up visits every 3 months. During these visits, weight and height were measured using a standard protocol and body mass index was calculated as kg/m 2 . A 24-h urinary specimen was obtained at baseline at follow-up visits every 6 months to measure urinary potassium, calcium and sodium content.
Salt sensitivity was measured at the end of the intervention. There was no reported method and criterion for the determination of sodium sensitivity in children. Based on previous studies 13, 14 with a little modification, we used a volume expansion and contraction protocol: sodium loading and volume expansion were achieved by the intravenous administration in 4 h, of 1 l normal (0.9%) saline to all subjects, on an empty stomach just after getting up. The average readings of three BP measurements made before salt loading was taken as the 'presaline' mean arterial BP (MABP was derived from the following formula: diastolic pressure þ 1/3 pulse pressure). At the end of the saline infusion, BP was again measured to determine the 'postsaline' MABP. On the following day, sodium and volume depletion were accomplished by administration of a 10 mmol sodium diet and three 20-mg doses of furosemide given at 10:00 a.m., 2:00 p.m. and 6:00 p.m. BP was again measured 3 times after 2 h of ambulation the following morning at 8:00 a.m., and the 'post-furosemide' MABP was calculated. If the summation from the increase of 'postsaline' MABP after salt loading and the decrease of 'postfurosemide' MABP after sodium depletion was equal to or exceeding 10 mmHg, the subject was deemed to be sodium sensitive (SS), and if the summation o10 mmHg, the subject was judged as nonsodium sensitive (NSS).
Statistical analysis
Statistical analyses included ANOVA, paired and unpaired t-tests, w 2 test and Fisher's exact test. The increased value of BP (end point BPÀbaseline BP) and the BP increase range ((end point BPÀbaseline BP)/baseline BP Â 100) were calculated. All calculations were performed with SAS Software.
Results
Of the 308 children in six classes, one was excluded because of secondary hypertension at baseline screening and six children were rejected from participatation. During the 2 years of intervention, 22 children transfered school, 11 discontinued school, 7 were rejected from participating in salt sensitivity measurements including IV infusion of saline and oral administration. At the end of the study, 261 subjects had completed detail information (supplementation: 136; placebo control: 125).
In 261 student's detection results, 56 of them (21.5%) were deemed to be SS, and 205 participants of them (78.5%) were considered as NSS. In the supplemental group, 30 of them (22.1%) were SS, and 106 of them (77.9%) were NSS; and in the placebo control group, 26 subjects (20.8%) were SS and 99 examples (79.2%) were NSS. There was no significant difference in age, sex, height, weight, etc between each group either at baseline or at end point examination (P40.05) ( Tables 1 and 2 ).
The effect of potassium and calcium supplementation on SS children's BP changes is evaluated (see Table 3 ). In the SS children subgroup, the average increased value of BP (SBP/DBP, mmHg) in children who took potassium and calcium supplement was 4.3/4.8 mmHg lower (Po0.05) than that of children who took placebo, and the BP increase range (SBP/ DBP, %) was 4.4/8.7 percentage lower (Po0.05) than that of control children, while in the NSS children, there was no significant difference between the two groups (P40.05).
Potassium and calcium supplementation induced urinary sodium excretion changes in SS children (see Table 4 ): urinary sodium exretion showed a remarkable increase in SS children (Po0.01), there were no significant changes in NSS children (P40.05). Further analysis revealed an inverse correlation between the 2-year increased range of BP and the increased value of night urinary sodium exretion in SS children (r ¼ À0.39, Po0.01).
Discussion
Epidemiology studies have demonstrated that human urinary potassium excretion, urinary potassium/sodium ratio and the amount of diet potassium and calcium intake are inversely associated with arterial pressure in different populations. [15] [16] [17] Increasing potassium intake may increase urinary sodium excretion and reduce urinary calcium excretion. 1, 2 This may remind us that moderate increase in ingestion of potassium and calcium can act as a primary prevention method of hypertension. However, a population test revealed that replenishment with potassium and calcium has a different effect on BP in different individuals just as that of salt restriction. 5, 6, [9] [10] [11] 18 Salt sensitiveness is a kind of hereditary defect existing in some individuals within the human population, and it is a kind of intermediate phenotype of hypertension. 7, 8 If one is SS, longterm exposure to a high-salt diet environment will lead to high BP. Results of our randomized, doubleblinded, placebo-controlled clinical trial in Chinese children suggest that long-term increase in potassium and calcium intake in SS children can significantly reduce the age-related increase in range of BP, while such an effect is not found in NSS children. This information may show that the antagonizing effect of potassium and calcium supplementation on a child's BP increasing with age is related to salt sensitiveness, a kind of hereditary quality related to salt; that is to say potassium and calcium supplementation mainly influences SS children's BP.
Several reports have already pointed out potassium's antipressor biological effect on sodium, and calcium's obvious protective function against sodium-loading-induced hypertension. [3] [4] [5] [6] But so far, the interaction among the potassium, calcium and sodium ions, and the function in generating and protecting against high BP has not been expounded. A report points out in recent years that potassium and calcium ions seemingly lower BP, increasing urinary sodium excretion by reciprocal changes with the sodium ion. 15, 19 SS persons have hereditary membrane ions transporting defects and kidneyrelated obstacles of sodium excretion, and consuming a diet with high salt for a long time can bring about high BP owing to prolonged sodium retention. Our previous study also found that a SS patient's urinary sodium elimination was obviously lower than normal, and red blood cell sodium ion density significantly higher than that of NSS person. 13 The results of this study indicated that supplementation of potassium and calcium for a long time can promote SS children's kidney elimination of sodium, which is inversely associated with the BP increase in degree presenting within SS children, but without notable suppressive influence on kidney sodium excretion in a NSS person. It may be explained that improving potassium levels and increasing calcium levels in SS children can promote urinary sodium elimination and reduce sodium retention through a complex interaction function among ions, thereby suppressing BP increase with age. An epidemiological study and experimental investigation found that 25% of the general population and 50% of hypertensive patients or persons with high BP family history are SS. 20 In this study, 21.5% of the enrolled children presented salt sensitivity. Long-term salt diet restriction is considered to be the exclusive effective measure for preventing hypertension of SS persons. The research results may suggest that, long-term administration of potassium and calcium to SS children can notably promote their urinary sodium elimination and reduce sodium retention; thereby slowing down the range of BP increase with ageing, and then contributing to the prevention of hypertension.
These results were especially noteworthy since, to our knowledge, no other randomized controlled trials of potassium and calcium supplementation have been conducted in Chinese children, who traditionally consume a low potassium and calcium diet.
